Q2 2025 Management View CEO Sean E. Brynjelsen stated that "it was another record quarter for the company" and described 2025 ...

Q3 2025 Management View CEO Cheryl P. Beranek highlighted third quarter net sales of $49.9 million, up 2% over the same ...

This week brings the launch of a fresh rolling carry-on tote from Hulken, a Lego recreation of an Italian Riviera and an ...

If your product doesn’t require a token to function, focus on achieving product-market fit (PMF) first. Launching a token too ...

Mercedes-Benz is set to launch 18 new models by 2026, including EVs, facelifts, and performance cars. From the S-Class to AMG ...

Selena Gomez commanded the spotlight as she unveiled her latest product, while celebrating the 5th anniversary of her brand ...

I previewed GPT-5 before the launch and pretty much everything that we expected was announced. Below, I will talk about what ...

Press Release Joinable Labs today announced its official launch, emerging from stealth with a bold mission: to help AI ...

After 10 years of development, the company is working to go to market with a gel patch to repair perforated eardrums.

Discover insights from Cytek Biosciences' Q2 2025 earnings call. Learn about revenue trends, recurring growth, new product launches, and future outlook.

Operating cash flow was just under $28 million, and the company ended the quarter with approximately $50 million in net cash. EPS was $0.59 per share, or $0.63 per share excluding one-time items.